1. Zhang, Xin, Duan, Yajun, Li, Su, Qian, Minxian, Wang, Zhongyuan. 2024. CRISPR screening identifies PRMT1 as a key pro-ferroptotic gene via a two-layer regulatory mechanism. In Cell reports, 43, 114662. doi:10.1016/j.celrep.2024.114662. https://pubmed.ncbi.nlm.nih.gov/39178116/
2. Liu, Jing, Bu, Xia, Chu, Chen, Freeman, Gordon J, Wei, Wenyi. 2023. PRMT1 mediated methylation of cGAS suppresses anti-tumor immunity. In Nature communications, 14, 2806. doi:10.1038/s41467-023-38443-3. https://pubmed.ncbi.nlm.nih.gov/37193698/
3. Luo, Li, Wu, Xingyun, Fan, Jiawu, Jiang, Jingwen, Wang, Kui. 2024. FBXO7 ubiquitinates PRMT1 to suppress serine synthesis and tumor growth in hepatocellular carcinoma. In Nature communications, 15, 4790. doi:10.1038/s41467-024-49087-2. https://pubmed.ncbi.nlm.nih.gov/38839752/
4. Li, Wen-Juan, Huang, Ying, Lin, Yi-An, Deng, Xianming, Liu, Wen. 2023. Targeting PRMT1-mediated SRSF1 methylation to suppress oncogenic exon inclusion events and breast tumorigenesis. In Cell reports, 42, 113385. doi:10.1016/j.celrep.2023.113385. https://pubmed.ncbi.nlm.nih.gov/37938975/
5. Djajawi, Tirta M, Pijpers, Lizzy, Srivaths, Akash, Johnstone, Ricky W, Kearney, Conor J. 2024. PRMT1 acts as a suppressor of MHC-I and anti-tumor immunity. In Cell reports, 43, 113831. doi:10.1016/j.celrep.2024.113831. https://pubmed.ncbi.nlm.nih.gov/38401121/
6. Li, Zhongwei, Wang, Diandian, Lu, Jun, Zheng, Junnian, Bai, Jin. 2020. Methylation of EZH2 by PRMT1 regulates its stability and promotes breast cancer metastasis. In Cell death and differentiation, 27, 3226-3242. doi:10.1038/s41418-020-00615-9. https://pubmed.ncbi.nlm.nih.gov/32895488/
智鼠故事 
